首页 | 本学科首页   官方微博 | 高级检索  
     

桂枝茯苓胶囊与米非司酮联合治疗子宫肌瘤患者的临床疗效及安全性
引用本文:金珊珊. 桂枝茯苓胶囊与米非司酮联合治疗子宫肌瘤患者的临床疗效及安全性[J]. 中国药物经济学, 2021, 0(2): 42-45
作者姓名:金珊珊
作者单位:沈阳市妇婴医院妇产科
摘    要:目的 探讨桂枝茯苓胶囊与米非司酮联合治疗子宫肌瘤患者的临床疗效及安全性.方法 选取2017年4月至2020年4月于沈阳市妇婴医院就诊的106例子宫肌瘤患者作为研究对象,随机分为对照组与观察组,每组53例.对照组给予米非司酮,观察组在对照组治疗基础上联合桂枝茯苓胶囊治疗,比较两组的治疗效果.结果 观察组治疗有效率高于对照...

关 键 词:桂枝茯苓胶囊  米非司酮  子宫肌瘤  安全性  性激素  治疗有效率

Clinical Evaluation and Safety of Guizhi Fuling Capsule Combined with Mifepristone in the Treatment of Patients with Uterine Fibroids
JIN Shan-Shan. Clinical Evaluation and Safety of Guizhi Fuling Capsule Combined with Mifepristone in the Treatment of Patients with Uterine Fibroids[J]. China Journal of Pharmaceutical Economics, 2021, 0(2): 42-45
Authors:JIN Shan-Shan
Affiliation:(Department of Obstetrics and Gynecology,Shenyang Maternity Hospital,Shenyang 110011,China)
Abstract:Objective To evaluate the clinical efficacy and safety of Guizhi Fuling Capsule combined with mifepristone in the treatment of uterine fibroids.Methods A total of 106 patients with uterine fibroids admitted to Shenyang Maternity Hospital were selected as the research objects and were randomly divided into a control group and an observation group,with 53 patients in each group.The control group was given mifepristone,and the observation group given Guizhi FuLing Capsule plus mifepristone.The therapeutic effect was compared.Results The effective rate of treatment in the observation group was higher than that in the control group,and the incidence of adverse reactions was lower than that in the control group,the difference was statistically significant(P<0.05);after treatment,sex hormone levels,uterine fibroids volume,uterine volume,quality of life and safety of the 2 groups were superior to the control group,the difference was statistically significant(P<0.05).Conclusion The combination of Guizhi Fuling capsule and mifepristone is effective and safe in the treatment of uterine fibroids.
Keywords:Guizhi Fuling capsule  Mifepristone  Uterine fibroids  Security  Sex hormones  Total effective rate
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号